Previous Article | Next Article ![]()
Journal of Virology, July 2002, p. 6852-6856, Vol. 76, No. 13
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.13.6852-6856.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Sangeeta Shah,3,
Phuong Nguyen,1 John D. Altman,4 and Marcia A. Blackman1,2,3*
Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105,1 Department of Pathology, University of Tennessee, Memphis, Tennessee 38163,2 Trudeau Institute, Saranac Lake, New York 12983,3 Emory Vaccine Center, Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 303224
Received 19 December 2001/ Accepted 21 March 2002
|
|
|---|
|
|
|---|
Bacterial superantigens are potent immunostimulatory molecules expressed by common strains of gram-positive bacteria, including staphylococci and streptococci. Upon binding to the Vß element of the T-cell receptor (TCR), superantigens activate T cells to proliferation, cytokine secretion, and/or cytotoxicity, followed by deletion or anergy (2, 16). Because superantigens are specific for the Vß element of the TCR rather than the antigen combining site, they activate a high percentage of T cells. For example, staphylococcal enterotoxin B (SEB) activates murine Vß8+ T cells, which represent
30% of total T cells in most mouse strains, including C57BL/6. Whereas the effects of superantigens on naïve T cells have been well characterized, less is known about the effects on memory T cells. We have previously shown that SEB activates influenza virus-specific memory CD8+ T cells and drives them to cytolytic effector function (3). This demonstration that superantigens can activate memory CD8+ T cells prompted the question of whether superantigen administration to mice that had recovered from influenza virus infection 6 to 8 weeks earlier (influenza memory mice) would have an impact on the repertoire of memory T cells established to an earlier infection.
In the current study, the consequence of superantigen exposure on the repertoire of CD8+ memory T cells was examined in a well-characterized murine influenza model. The memory response to influenza virus in C57BL/6 mice is directed largely toward a single, immunodominant epitope in the nucleoprotein molecule, NP366-374, presented by Db (1, 8, 23). We had previously shown that Vß8.3+ T cells represent a significant proportion of the response to NP366-374/Db in B6 mice (5, 8, 13). Since Vß8.3+ T cells are also SEB reactive, we employed this system to examine the long-term effects of SEB on both Vß8.3+ (SEB reactive) and total NP-specific memory CD8+ T cells.
Influenza memory mice were generated by intranasal infection of C57BL/6 mice with 240 hemagglutinating units (HAU) of A/HKx31 virus (x31 virus) (4). To assess the effect of bacterial superantigens on previously established memory CD8+ T cells, influenza memory mice were exposed to SEB. In some experiments, staphylococcal enterotoxin A (SEA), which specifically activates murine T cells expressing Vßs 1, 3, and 11, was administered as a control. Endotoxin-free superantigens (Toxin Technology, Sarasota, Fla.) (26) and phosphate-buffered saline (PBS) were administered to influenza memory mice via surgically implanted Alzet miniosmotic pumps (Alza, Palo Alto, Calif.) that released 2 µg of SEB or 0.1 µg of SEA per h over a period of 7 days (14, 18). Preliminary studies showed that, as expected, the SEB pumps caused Vß-specific expansion and deletion. However, because the pumps release low, sustained doses of SEB, there was a lower effective concentration and a sustained presence of SEB (data not shown). Because the goal of these experiments was to assess the long-term effects of superantigen exposure on the preexisting memory T-cell repertoire, the influenza memory mice were rested for 4 to 8 weeks after superantigen exposure prior to being analyzed to allow resolution of the acute in vivo response and to ensure that stable effects on the memory repertoire were being measured.
As a first step in assessing the effect of SEB exposure on the long-term influenza virus-specific memory CD8+-T-cell repertoire, the effect of SEB on the numbers of NP+ and Vß8.3+ NP+ memory CD8+ T cells in the spleens of influenza memory mice before secondary challenge was assessed by three-color fluorescence-activated cell sorting (FACS) analysis (13). NP-specific T cells were identified with a tetrameric reagent, the H-2Db glycoprotein complexed with the influenza virus NP366-374 peptide conjugated with phycoerythrin (NP366-374/Db) (8). The data (Table 1) show that there was no significant effect of prior SEB exposure on either total CD8+ T cells or NP+ CD8+ T cells in the spleens of influenza memory mice. However, there was a statistically significant reduction in the Vß8.3+ subset of NP+ T cells, which are SEB reactive.
|
View this table: [in a new window] |
TABLE 1. SEB treatment of influenza memory mice causes significant reduction in the numbers of Vß8.3+ NP+ memory CD8+ T cells in the spleena
|
![]() View larger version (25K): [in a new window] |
FIG. 1. Superantigen treatment reduces the proportion of virus-specific cells bearing cross-reactive TCRs in the BAL fluid of influenza memory mice after secondary viral challenge. Nonadherent cells isolated from the BAL fluid of influenza memory mice that had been treated with PBS, SEB, or SEA 1 to 2 months prior to secondary challenge were tested for total NP tetramer-positive cells (A) and Vß8.3+ T cells among the NP tetramer-positive cells (B). The data were compiled from several experiments, and each data point represents analysis of an individual animal. Statistical significance (PBS versus SEB), determined by Student's t test: *, P < 0.005; **, P < 0.05; ***, P < 0.000005. Representative three-color FACS analysis of gated CD8+ T cells used to determine the proportion of Vß8.3+ cells among NP tetramer-positive cells is also shown (C).
|
|
View this table: [in a new window] |
TABLE 2. SEB treatment of influenza memory mice causes a significant reduction in the numbers of Vß8.3+ NP+ T cells elicited in BAL fluid upon secondary viral challengea
|
![]() View larger version (30K): [in a new window] |
FIG. 2. SEB-treated influenza memory mice have a delayed response to secondary viral challenge. Influenza memory mice (8 weeks after primary infection) were treated with PBS, SEB, or SEA. Eight weeks later, the mice were challenged intranasally with PR8, and nonadherent BAL fluid cells were assayed for CTL activity against NP366-374 peptide-labeled targets (solid symbols) or target cells alone (open symbols) at days 5, 7, and 8 after secondary challenge. Three representative experiments are shown for analysis at day 5 (A), and single representative experiments are shown for analysis at days 7 and 8 (B). The data shown are representative of eight independent experiments.
|
![]() View larger version (21K): [in a new window] |
FIG. 3. SEB treatment alters the TCR Vß repertoire of NP+ CD8+ T cells elicited in the BAL fluid after secondary viral infection. The TCR Vß repertoire of BAL fluid cells elicited 5 days after secondary viral challenge with PR8 was assessed by three-color FACS with a panel of antibodies specific for most of the murine TCR Vß elements (13). Data are expressed as the percentage of CD8+ T cells expressing a particular TCR Vß element among the NP tetramer-positive (A) or NP tetramer-negative (B) CD8+ T cells. The data shown are from a single, representative analysis of pooled data from five mice. The deletion of Vß8.3+ NP+ T cells by SEB was consistently seen in three independent experiments, whereas the TCR Vß expression of compensating T cells varied between experiments.
|
In order to determine whether the SEB-induced repertoire perturbations impacted protective immunity, viral clearances after secondary challenge of PBS- and SEB-treated influenza memory mice were compared. Initial results showed no effect on viral clearance (data not shown), consistent with previous observations after depletion of all Vß8+ T cells by in vivo antibody treatment (5). These results are consistent with the idea that repertoire plasticity can effectively compensate for losses of major components of the repertoire (4, 6, 7). Recent studies showed concurrent primary responses during the recall response after secondary viral challenge (24). Therefore, the viral clearance experiments were repeated in mice that had been thymectomized prior to initial viral infection to eliminate the possible compensation of an SEB-induced defect in the memory response by naïve T cells that had emigrated from the thymus after SEB exposure.
Virus titers in the lungs of thymectomized and sham-thymectomized influenza memory mice that had been treated with PBS or SEB were assessed by a standard plaque assay (9) on days 6, 7, and 8 after secondary infection. The results (Table 3) show a delay in viral clearance in thymectomized but not sham-thymectomized SEB-treated influenza memory mice. In these experiments, thymectomy is predicted to impact the naïve rather than the memory repertoire, as persistence of memory T cells is independent of thymic output of naïve T cells (22). Therefore, these data suggest that the delayed viral clearance in SEB-treated thymectomized mice is a consequence of a reduced contribution of naïve CD8+ T cells to control of the viral challenge. This possibility can be directly tested by adoptively transferring naïve CD8+ T cells into thymectomized mice prior to secondary challenge. However, the mice still cleared the virus, consistent with the plasticity of the memory repertoire.
|
View this table: [in a new window] |
TABLE 3. SEB treatment of influenza memory mice causes delayed viral clearance after secondary viral challenge in thymectomized and aged micea
|
Finally, the current experiments do not address the effect of SEB, thymectomy, or aging on virus-specific CD4+ T cells, which contribute both directly and indirectly to CD8+-T-cell recall responses (25). In this regard, it has been shown that CD4+ and CD8+ memory T cells are maintained differently (12), and in contrast to CD8+ memory T cells, memory CD4+ T cells have been shown to be nonresponsive to superantigen stimulation (3, 11, 15).
In conclusion, the present report shows that bacterial superantigen exposure profoundly affects the TCR repertoire of memory CD8+ T cells and the kinetics of the recall CTL response after secondary viral challenge. This effect is in contrast to our previous studies, in which we found no consequences of concurrent exposure to SEB and influenza virus on the generation of virus-specific memory CD8+ T cells (13). That bacterial superantigens have different effects on the generation and maintenance of memory cells is not surprising. Importantly, the data are consistent with the idea that, even when the CD8+-T-cell response to an immunodominant epitope is mediated by a limited repertoire of T cells, there is remarkable plasticity to the repertoire, and T cells bearing other TCRs can effectively compensate. There are limits to the plasticity, however, and in cases of severe repertoire perturbation, the response may be diverted to other, normally subdominant epitopes (4, 6) and may result in delayed viral clearance (7).
Immune individuals are probably exposed to bacterial superantigens with relatively high frequency, either in the context of bacterial infections or as isolated toxins as a consequence of food poisoning. Therefore, the ability of superantigens to perturb the repertoire of memory CD8+ T cells may be of significant clinical relevance, especially as the plasticity of the repertoire may diminish with age, making repertoire perturbations functionally more relevant in older individuals.
We thank David Woodland for many helpful and provocative discussions.
This work was supported by National Institutes of Health grants AI38349 (M.A.B.) and AI42373 (J.D.A.), P30 CA21765 (CORE grant), the American Lebanese Syrian Associated Charities (ALSAC), and the Trudeau Institute.
Present address: AbGenomics, Taipei, Taiwan. ![]()
Present address: Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33136. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»